510(k) device
Trevo Trak 21 Microcatheter
Stryker Neurovascular · Catheter, Percutaneous, Neurovasculature (QJP, Class II) · First FDA decision Nov 26, 2021, newest Jul 1, 2026Acute ischemic strokeBrain aneurysm
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "Trevo Trak 21"
MAUDE reports
10
Brand "Trevo Trak 21", since 2015
PubMed studies
0
Mentioning "Trevo Trak 21"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Trevo Trak 21 Microcatheter
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K261889 · Decided Jul 1, 2026 · 26 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
K211594 · Decided Nov 26, 2021 · 186 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Trevo Trak 21", any status and sponsor, newest update first.
No registered device study names "Trevo Trak 21".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Trevo Trak 21", and for the whole product code for context.
This brand
10 reports: 7 malfunction, 2 injury, 1 death
Whole product code QJP
1,927 reports: 1,580 malfunction, 295 injury, 52 death
Newest reports for this brand
- TREVO TRAK 21 MICROCATHETER 162CMMalfunction
STRYKER NEUROVASCULAR-UTAH-SALT LAKE CITY
3012931345-2025-00114 · Received Jul 9, 2025 · Event dated Jun 18, 2025
Device type: Catheter, Percutaneous, Neurovasculature (QJP)
Device problem as coded: Fracture
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- TREVO TRAK 21 MICROCATHETER 162CMMalfunction
STRYKER NEUROVASCULAR-UTAH-SALT LAKE CITY
3012931345-2025-00085 · Received Apr 30, 2025 · Event dated Jan 30, 2025
Device type: Catheter, Percutaneous, Neurovasculature (QJP)
Device problem as coded: Peeled/Delaminated
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- TREVO TRAK 21 MICROCATHETER 162CMMalfunction
STRYKER NEUROVASCULAR-UTAH-SALT LAKE CITY
3012931345-2023-00051 · Received Mar 21, 2023 · Event dated Jan 10, 2023
Device type: Catheter, Intravascular, Diagnostic (DQO)
Device problem as coded: Material Puncture/Hole
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0021-2025 · Started Aug 30, 2024 · Posted by FDA Oct 7, 2024
Reason given: Stryker Neurovascular has observed that devices with Out of United States (OUS) approved Instructions for Use (IFU) and Packaging Labels (pouch and carton), different configurations, have been erroneously distributed to customers in the US.
Cause as FDA categorized it: Under Investigation by firm · Device type: Catheter, Percutaneous, Neurovasculature (QJP)
- Trevo Trak 21 Microcatheter, Catalog: 90338Open, Classified
Z-1906-2024 · Started Apr 23, 2024 · Posted by FDA May 28, 2024
Reason given: Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may exceed the acceptable limits of endotoxin levels; high levels of endotoxins may increase the risk of fever, shock and...
Cause as FDA categorized it: Process design · Device type: Catheter, Percutaneous, Neurovasculature (QJP)
Z-1085-2024 · Started Dec 6, 2023 · Posted by FDA Feb 14, 2024
Reason given: The microcatheter IFU contains an intended use that has not been evaluated by the FDA.
Cause as FDA categorized it: Under Investigation by firm · Device type: Catheter, Percutaneous, Neurovasculature (QJP)
Published research
The most relevant PubMed records for "Trevo Trak 21"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QJP.
- Route 92 Medical Full Length 046 Access SystemRoute 92 Medical, Inc. · 510(k) 2026
- TracStar LDP Large Distal PlatformImperative Care, Inc. · 510(k) 2024
- Millipede 088 Access CatheterPerfuze, Ltd. · 510(k) 2023
- Path BgcCrossroads Neurovascular, Inc. · 510(k) 2026
- AXS Lift Intracranial Base CatheterStryker Neurovascular · 510(k) 2026
- VersaD Delivery CatheterUnity Medical, Inc. · 510(k) 2025
- Radical the Dude 8F Guide CatheterMaduro Medical, Inc. · 510(k) 2025
- Next Generation Access PlatformBalt USA, LLC · 510(k) 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.